CORMORANT ASSET MANAGEMENT, LP – Monte Rosa Therapeutics, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$24.45M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
-15.51%
quarter
Monte Rosa Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | -4.49M | $8.17 | 2.99M | |
| Q2 2022 | share | Decrease | -0.28% | -8.48K shares | -13.14M | $9.67 | 2.99M |
| Q1 2022 | share | 0.00% | 0 shares | -19.21M | $14.02 | 3.00M | |
| Q4 2021 | share | Decrease | -3.22% | -100K shares | -6.65M | $20.9 | 3.00M |
| Q3 2021 | share | Decrease | -2.87% | -91.77K shares | -1.59M | $22.28 | 3.10M |
| Q2 2021 | share | Increase | 0.00% | 3.19M shares | 69.55M | $22.7 | 3.19M |